share_log

兴科蓉医药(06833.HK)3月26日举行董事会会议考虑及批准年度业绩

Xingkerong Pharmaceutical (06833.HK) held a board meeting on March 26 to consider and approve annual results

Gelonghui Finance ·  Mar 14 05:51

Gelonghui, March 14, 丨 Xingkerong Pharmaceutical (06833.HK) announced that the company will hold a board meeting on March 26, 2024 (Tuesday) to consider and approve the results and publication of the company and its subsidiaries for the year ended 31 December 2023, and to consider recommending payment of a final dividend (if any).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment